Prostate 3

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer TreatmentsF

High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent [...]


Rituxan Improves Survival in Young Adults with Acute Lymphoblastic Leukemia

Acccording to results recently published in the New England Journal of Medicine, young adults with CD20-positive, Philadelphia chromosome  (PH)-negative acute lymphoblastic leukemia (ALL), experience survival [...]


National Ovarian Cancer Coalition Launches CancerConnect Social Media Platform for Women with Ovarian Cancer

Austin TX/Sun Valley ID–The National Ovarian Cancer Coalition (NOCC) now offers a specialized social network for women with ovarian cancer. The NOCC CancerConnect Community offers [...]


CDC Vaccine Information and Recommendations for the 2016/17 Influenza Season

With the start of a new school year and the approaching winter, it’s time to get informed about the most critical information regarding the 2016/17 [...]


Have a Question about Metastatic Breast Cancer? Ask the Expert!

Join us on October 10th! October 10th, 6:00-7:00 PM, EST Tune in here. Join us for a live Ask the Expert session with Memorial Sloan [...]

Melanoma 2

Cotellic®/Zelboraf® Combo: New Standard of Care for Melanoma

The treatment combination consisting of Cotellic® (cobimetinib) plus Zelboraf® (vemurafenib) improves overall survival for patients with advanced, BRAF (V600) mutation-positive melanoma. These confirmatory results have [...]

Pancreatic 3

Pass it On: It’s National Ovarian Cancer Awareness Month

In 2016, the American Cancer Association estimates that 22,280 women will be diagnosed with ovarian cancer, and 14,240 women will die from the disease. The [...]


Announcing the CancerConnect Head and Neck Cancer Support Community

Your story matters. Head and neck cancer is a challenging diagnosis, connecting with others who have had to deal with the side effects of treatment [...]


FDA Grants Breakthrough Therapy Designation to Keytruda® for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Keytruda® (pembrolizumab) for first-line treatment of patients with advanced non-small cell lung [...]


Whole-Brain Radiotherapy Fails to Benefit Most Patients with Lung Cancer

Whole-brain radiotherapy (WBRT) provides "little additional clinically significant benefit" for patients with non–small cell lung cancer (NSCLC) with brain metastases, according to doctors performing the [...]

« More News Tips & Features